rs142948530

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_005422.4(TECTA):​c.5012C>T​(p.Ser1671Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00721 in 1,614,188 control chromosomes in the GnomAD database, including 58 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0064 ( 8 hom., cov: 31)
Exomes 𝑓: 0.0073 ( 50 hom. )

Consequence

TECTA
NM_005422.4 missense

Scores

1
4
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:8

Conservation

PhyloP100: 7.47
Variant links:
Genes affected
TECTA (HGNC:11720): (tectorin alpha) The tectorial membrane is an extracellular matrix of the inner ear that contacts the stereocilia bundles of specialized sensory hair cells. Sound induces movement of these hair cells relative to the tectorial membrane, deflects the stereocilia, and leads to fluctuations in hair-cell membrane potential, transducing sound into electrical signals. Alpha-tectorin is one of the major noncollagenous components of the tectorial membrane. Mutations in the TECTA gene have been shown to be responsible for autosomal dominant nonsyndromic hearing impairment and a recessive form of sensorineural pre-lingual non-syndromic deafness. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007885486).
BP6
Variant 11-121162110-C-T is Benign according to our data. Variant chr11-121162110-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 45335.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Benign=6, Uncertain_significance=1}. Variant chr11-121162110-C-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00637 (971/152376) while in subpopulation NFE AF= 0.00958 (652/68036). AF 95% confidence interval is 0.00897. There are 8 homozygotes in gnomad4. There are 479 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 8 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TECTANM_005422.4 linkuse as main transcriptc.5012C>T p.Ser1671Leu missense_variant 16/24 ENST00000392793.6 NP_005413.2
TBCEL-TECTANM_001378761.1 linkuse as main transcriptc.5954C>T p.Ser1985Leu missense_variant 22/30 NP_001365690.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TECTAENST00000392793.6 linkuse as main transcriptc.5012C>T p.Ser1671Leu missense_variant 16/245 NM_005422.4 ENSP00000376543 P4

Frequencies

GnomAD3 genomes
AF:
0.00638
AC:
971
AN:
152258
Hom.:
8
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00113
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00713
Gnomad ASJ
AF:
0.0124
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.0103
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00958
Gnomad OTH
AF:
0.00334
GnomAD3 exomes
AF:
0.00546
AC:
1371
AN:
251186
Hom.:
7
AF XY:
0.00531
AC XY:
721
AN XY:
135810
show subpopulations
Gnomad AFR exome
AF:
0.00135
Gnomad AMR exome
AF:
0.00243
Gnomad ASJ exome
AF:
0.0131
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000817
Gnomad FIN exome
AF:
0.00947
Gnomad NFE exome
AF:
0.00773
Gnomad OTH exome
AF:
0.00423
GnomAD4 exome
AF:
0.00730
AC:
10669
AN:
1461812
Hom.:
50
Cov.:
30
AF XY:
0.00721
AC XY:
5244
AN XY:
727216
show subpopulations
Gnomad4 AFR exome
AF:
0.00114
Gnomad4 AMR exome
AF:
0.00246
Gnomad4 ASJ exome
AF:
0.0148
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000730
Gnomad4 FIN exome
AF:
0.00914
Gnomad4 NFE exome
AF:
0.00829
Gnomad4 OTH exome
AF:
0.00603
GnomAD4 genome
AF:
0.00637
AC:
971
AN:
152376
Hom.:
8
Cov.:
31
AF XY:
0.00643
AC XY:
479
AN XY:
74522
show subpopulations
Gnomad4 AFR
AF:
0.00113
Gnomad4 AMR
AF:
0.00712
Gnomad4 ASJ
AF:
0.0124
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.0103
Gnomad4 NFE
AF:
0.00958
Gnomad4 OTH
AF:
0.00331
Alfa
AF:
0.00803
Hom.:
9
Bravo
AF:
0.00522
TwinsUK
AF:
0.00836
AC:
31
ALSPAC
AF:
0.00934
AC:
36
ESP6500AA
AF:
0.00204
AC:
9
ESP6500EA
AF:
0.00768
AC:
66
ExAC
AF:
0.00505
AC:
613
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:8
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:3
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMay 07, 2012Ser1671Leu in Exon 15 of TECTA: This variant is not expected to have clinical si gnificance because it has been identified in 0.7% (52/7020) of European American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http ://evs.gs.washington.edu/EVS; dbSNP rs142948530). -
Benign, criteria provided, single submitterclinical testingGeneDxJan 23, 2018This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Dec 09, 2014- -
not provided Benign:3
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJun 01, 2024TECTA: BS2 -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsJul 08, 2019- -
Autosomal recessive nonsyndromic hearing loss 21 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
Autosomal dominant nonsyndromic hearing loss 12 Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
TECTA-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesJul 23, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Benign
0.29
T;.;T
Eigen
Benign
0.057
Eigen_PC
Uncertain
0.26
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.90
.;D;D
M_CAP
Benign
0.012
T
MetaRNN
Benign
0.0079
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.1
L;.;L
MutationTaster
Benign
1.0
D;D
PrimateAI
Uncertain
0.59
T
PROVEAN
Benign
-1.7
N;.;N
REVEL
Benign
0.13
Sift
Benign
0.17
T;.;T
Sift4G
Benign
0.16
T;.;T
Polyphen
0.17
B;.;B
Vest4
0.63
MVP
0.71
MPC
0.31
ClinPred
0.011
T
GERP RS
5.5
Varity_R
0.17
gMVP
0.55

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs142948530; hg19: chr11-121032819; COSMIC: COSV50755443; API